AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

DULOXETINE HYDROCHLORIDE in Zimbabwe

10 products registered with MCAZ β€” 10 active

Brand / ProductReg. No.HolderStatusExpires
DULATINE 60
CAPSULE; ORAL
2026/13.2.1/7332EMCURE PHARMACEUTICALS LTDactive3 Mar 2031
DULATINE 30
CAPSULE; ORAL
2026/13.2.1/7331PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTDactive3 Mar 2031
DULOXETINE 30MG MYLAN
CAPSULE; ORAL
2025/13.2.1/7049MYLAN LABORATORIES LIMITEDactive26 Aug 2030
DULOXETINE 60MG MYLAN
CAPSULE; ORAL
2025/13.2.1/7050MYLAN LABORATORIES LIMITEDactive26 Aug 2030
HENKA 30
CAPSULE
2024/13.2.1/6583HETERO LABS LTDactive31 Dec 2027
DUELOKS 30
CAPSULE; ORAL
2018/13.2.1/5654INNOVATA PHARMACEUTICALS LTDactive31 Dec 2027
DEULOKS 60
CAPSULE; ORAL
2018/13.2.1/5653INNOVATA PHARMACEUTICALS LTDactive31 Dec 2027
HENKA 60
CAPSULE
2024/13.2.1/6584HETERO LABS LTDactive31 Dec 2027
JOYTOR 30
CAPSULE
2025/13.2.1/6984TORRENT PHARMACEUTICALSactive31 Dec 2027
JOYTOR 60
CAPSULE
2025/13.2.1/6985TORRENT PHARMACEUTICALSactive31 Dec 2027

DULOXETINE HYDROCHLORIDE β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 10 registered products containing DULOXETINE HYDROCHLORIDE, of which 10 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track DULOXETINE HYDROCHLORIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Duloxetine Hydrochloride β€” Zimbabwe (MCAZ) | AfricaRegulatory